SUMMARY Plasma concentrations of atrial natriuretic peptide were measured in eight patients undergoing elective cardiac catheterisation and angiography. All patients had normal resting pressures in the cardiac chambers and no clinical evidence of heart failure. Plasma atrial natriuretic peptide rose significantly from the superior vena cava into the right atrium and right ventricle. The increase into the right atrium was variable, with no increase in three subjects, but there was a consistent increase in all subjects from the superior vena cava to the right ventricle. These findings in the right atrium are probably caused by inadequate mixing and streaming of blood from the coronary sinus containing high concentrations of atrial natriuretic peptide. There was no increase in the concentration of natriuretic peptide from the pulmonary artery to the left ventricle, but the concentrations in the left ventricle were significantly higher than in the superior vena cava.
These findings demonstrate that the heart secretes atrial natriuretic peptides in the absence of cardiac failure. Studies based on sampling of the right atrium will not accurately measure cardiac secretion of atrial natriuretic peptide and will therefore be likely to obscure the mechanisms responsible for regulating its secretion. The right ventricle and pulmonary artery are the best sampling sites to measure atrial natriuretic peptide release from the right atrium.
There is increasing evidence that atrial natriuretic peptide may be important in the regulation of salt and water balance. (8 6) pg/ml), in the righ-t ventricle (43 8 (7 7) pg/ml) and in the pulmonary artery (43 1 (6 8) pg/ml) were significantly-higher than the concentration in the superior vena cava (32-0 (54) pg/ml) ( fig 1) . Examination of individual changes from the superior vena cava into the right heart showed that in three of the eight subjects there was no change into the right atrium (fig 2a) the chambers of the heart within the same individual.
In our study, we considered in detail the changes in plasma concentrations of atrial natriuretic peptide in individual subjects with normal cardiac chamber pressures. We found three of the eight subjects had no increase in plasma atrial natriuretic peptide in the right atrium compared with the superior vena cava, but they did have an increase in the right ventricle. In a further three subjects the rise from the superior vena cava to the right atrium was greater than the rise from the superior vena cava to the right ventricle. The wide variability in changes in concentrations of atrial natriuretic peptide from the superior vena cava to the right atrium in the eight subjects is likely to be due to a combination of the effects of the large contribution of the coronary sinus to atrial natriuretic peptide secretion4-6 streaming of blood in the right atrium,13 and within patient variation in the positioning of the sampling catheter in the atrium. The rise in the concentration of atrial natriuretic peptide from the superior vena cava to the right ventricle and the pulmonary artery was very similar in all subjects; mixing of blood containing low concentrations of atrial natriuretic peptide with that containing high concentrations is more likely to have occurred by the time atrial blood has reached these sites. Therefore, studies based on sampling the right atrium 312 are unlikely to be appropriate for determining the mechanisms of secretion. They may suggest spurious correlations and obscure important factors that determine the release of atrial natriuretic peptide.
Studies of the release of atrial natriuretic peptide from the heart should include sampling of the right ventricle or pulmonary artery or both because this will give a more accurate reflection of atrial secretion than direct right atrial sampling. Although Richards et al5 and Sato et a16 used this approach they gave no evidence to support their contention that the pulmonary artery is the more appropriate sampling site.
There are several possible explanations for the lack of increase in plasma atrial natriuretic peptide from the pulmonary artery to the left ventricle that we found in this study. It may be that the left atrium does not secrete atrial natriuretic peptide. This is unlikely, because, although the Singer, Dean, Buckley, Sagnella, MacGregor judged by the absence of clinical features and by normal resting cardiac pressures, there was no significant correlation between plasma concentrations of atrial natriuretic peptide in the heart and right atrial pressure. However, the right ventricular systolic pressure did correlate significantly with concentrations of atrial natriuretic peptide within all cardiac chambers sampled. The relevance of these findings is not clear and the numbers in our study were too small to allow definite conclusions to be drawn from such -correlations.
Calculation of the secretion rate of atrial natriuretic peptide is based on several assumptions, but our study shows it should be possible to calculate approximate-secretion of atrial natriuretic peptide across the heart, particularly when cardiac output is measured simultaneously. Our findings indicate that previous reports in which mechanisms for the secretion of atrial natriuretic peptide by the heart were postulated from correlations between haemodynamic and physicochemical variables and concentrations of atrial natriuretic peptide measured in the right atrium should be re-evaluated and the findings confirmed by sampling, at sites at which mixing of blood is adequate.
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